Non-invasive diagnostic for endometriosis, adenomyosis and fibroids

About NextGen Jane

NextGen Jane is building a large-scale, longitudinal research platform centered on the 'menstrualome'—the molecular data contained in menstrual blood. The company recruits a community of menstruators to mail in used tampons via a patented collection kit, combining these samples with survey data to develop non-invasive diagnostics for conditions like endometriosis and to establish baseline menstrual health. Founded in 2015, the private company is pre-revenue and focused on clinical study recruitment and data generation to validate its platform and future diagnostic products.

Therapeutic Areas